Epidemiology of osteoporotic fractures in Andalusia, Spain, from 2000-2010
Med Clin (Barc). 2017 . pii: S0025-7753(17)30628-0. doi:10.1016/j.medcli.2017.06.070 Aguilar Del Rey FJ, Pérez González O. Más información
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)
J Bone Miner Res. 2017 Sep;32(9):1907-1914. doi: 10.1002/jbmr.3177. Epub 2017 Jul 7. The objective was to study the effect of parathyroidectomy (PTX) compared with observation (OBS) on bone mineral density (BMD) in g/cm2 and T-scores … Leer más
Comparison of the osteogenic, adipogenic, chondrogenic and cementogenic differentiation potential of periodontal ligament cells cultured on different biomaterials.
Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:1075-1084.doi: 10.1016/j.msec.2017.03.213. Epub 2017 Mar 24 Más información Barrera-Ortega CC, Hoz-Rodríguez L, Arzate H, Fonseca-García A, Pérez-Alvarez J, Rodil SE.
Tibiotalocalcaneal fusion with a cemented coated retrograde nail as a salvage procedure for infected ORIF of the ankle.
Rev Esp Cir Ortop Traumatol. 2017 Jul 3. pii: S1888-4415(17)30068-1. doi: 10.1016/j.recot.2017.04.004. Más información Herrera-Pérez M, Boluda-Mengod J, Gutierrez-Morales MJ, Pais-Brito JL.
Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review.
Med Oral Patol Oral Cir Bucal. 2017 Jul 1;22(4):e512-e519 Más información Lozano-Carrascal N, Salomó-Coll O, Hernández-Alfaro F, Gehrke SA, Gargallo-Albiol J, Calvo-Guirado JL.
Biodegradable PCL/fibroin/hydroxyapatite porous scaffolds prepared by supercritical foaming for bone regeneration.
Int J Pharm. 2017 Jul 15;527(1-2):115-125. doi: 10.1016/j.ijpharm.2017.05.038 Más información Diaz-Gomez L, García-González CA, Wang J, Yang F, Aznar-Cervantes S, Cenis JL,Reyes R, Delgado A, Évora C, Concheiro A, Alvarez-Lorenzo C
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
Lancet. 2017 Jul 26. doi: 10.1016/S0140-6736(17)31613-6. Más información Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS,Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, … Leer más
Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.
J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):322-327. doi: 10.1097/QAI.0000000000001396 Más información Güerri-Fernández R, Molina-Morant D, Villar-García J, Herrera S, González-Mena A, Guelar A, Trenchs-Rodríguez M, Díez-Pérez A, Knobel
10 years of denosumab treatment in postmenopausal women with osteoporosis:results from the phase 3 randomised FREEDOM trial and open-label extension
Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523. doi:10.1016/S2213-8587(17)30138-9. Epub 2017 May 22 Más información Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwiński E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster JY, Roux … Leer más
Effects of growth hormone treatment on growth late, bone, and mineral metabolism of young rats with uremia induced by adenine
Pediatr Res. 2017 Jul;82(1):148-154. doi: 10.1038/pr.2017.95. Más información Claramunt D, Gil-Peña H, Fuente R, García-López E, Hernández Frías O, Ordoñez FA, Rodríguez-Suárez J, Santos F.
